Delivery Order SPE2DR25D1053-SPE2DR26FT541
Award Date 11/3/25
Potential Completion Date 11/4/25
Potential Value $15K
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 9, 2025, for the supply of RINVOQ ER 15 mg tablets in quantities of 30 units. This firm fixed-price delivery order, valued at $27,148.78, represents a competitively awarded, non-set-aside contract with an ultimate completion date of September 10, 2025. The ordering activity reflects the federal government's continued reliance on AmerisourceBergen as a critical pharmaceutical vendor supporting...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 11, 2025, for the supply of RINVOQ ER 30 mg tablets (30-count units) under a firm fixed-price contract with a ceiling value of $6,223.30. This non-competitive delivery order is scheduled for ultimate completion by August 12, 2025, with performance taking place at AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. The award represents a continuation of AmerisourceBergen's role as a...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on October 24, 2025, for the supply of RINVOQ ER 15 mg tablets (30-count units) with a ceiling value of $14,714.46. This is a firm fixed-price delivery order with no set-aside designation, competitively awarded under open competition. The work is to be completed by October 27, 2025, with performance at the vendor's facility in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp is a major pharmaceutical...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 29, 2025, for the supply of RINVOQ ER 45 mg tablets (28-count units) under a firm fixed-price contract valued at $15,357.41. This non-set-aside delivery order, with an ultimate completion date of September 30, 2025, represents a procurement of pharmaceutical products to support federal medical supply requirements. The order will be performed at AmerisourceBergen's corporate office location in...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on October 27, 2025, for the supply of RINVOQ ER 15 mg tablets in a quantity of 30 units, with a contract value of $17,640.35. This is a firm fixed price delivery order with no set-aside designation, indicating the award was made through open competition. The ultimate completion date is October 28, 2025, and the place of performance is AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. This...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on November 3, 2025, for the supply of RINVOQ ER 30 mg tablets in quantities of 30 units. This is a firm fixed-price delivery order with a ceiling value of $28,092.32 and an ultimate completion date of November 4, 2025. The contract was competitively awarded with no set-aside designation. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor that serves as a...
- The Defense Logistics Agency awarded a competitive delivery order to AmerisourceBergen Drug Corp on October 27, 2025, for the supply of RINVOQ ER 15 mg tablets in quantities of 30 units. This contract, valued at $10,667.68, carries a firm fixed price structure with a completion date of October 28, 2025. The award is non-set-aside and leverages AmerisourceBergen's established relationship with DLA's Medical Supply Chain, through which the company serves as a critical pharmaceutical distributor...
- The U.S. Defense Department's Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on August 25, 2025, for RINVOQ ER 15 mg tablets in a quantity of 30 units, with a contract ceiling value of $6,823.63. This is a firm fixed price delivery order with an ultimate completion date of August 26, 2025, and represents a non-competitive award. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, served as the prime contractor for this pharmaceutical supply...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 14, 2025, for the supply of RINVOQ ER 30 mg tablets (30-unit packages) valued at $34,458.64. This competitively awarded, firm fixed-price delivery order represents a non-set-aside procurement with an ultimate completion date of July 15, 2025. The award supports the agency's pharmaceutical supply chain requirements, with performance based in Conshohocken, Pennsylvania, where AmerisourceBergen's...
- The Defense Logistics Agency Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on August 27, 2025, for RINVOQ ER 15 mg tablets (30-unit packaging) valued at $20,655.65. This firm fixed-price delivery order, with an ultimate completion date of August 28, 2025, represents a competitive award with no set-aside designation. The contract will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, leveraging the company's established...